期刊文献+

蛋白质组学在肿瘤防治研究中的应用

Application of proteomics to cancer prevention and therapy research
下载PDF
导出
摘要 随着人类基因组测序计划 (humangenomesequenceproject)的完成 ,产生了蛋白质组学 (proteomics) --研究细胞内全部蛋白质的组成及动态变化的一门新兴学科。恶性肿瘤是一种多种基因和蛋白质参与的复杂疾病。综述了在肿瘤防治中蛋白质组学的主要策略和技术 ,及其在肿瘤标志物的筛选和鉴定、肿瘤分类、预后、治疗效果的评价及肿瘤发生机制等方面的研究。 With the completion of the human genome sequence project, proteomics is an emerging research area about the global protein profiles and their dynamic changes in cell. Cancer is a kind of multi-faceted and complex disease involved in multi-genes and proteins. This review focuses on the main strategies and technology in proteomics and its application to cancer prevention and therapy study, including identification of cancer biomarkers, classification and prognosis of cancer,evaluction of therapeutic efficacy as well as elucidation of cancer mechanisms.
作者 杨文理 覃扬
出处 《肿瘤防治杂志》 CAS 2004年第6期659-662,共4页 China Journal of Cancer Prevention and Treatment
关键词 蛋白质组学 基因组学 肿瘤 肿瘤预防 肿瘤治疗 proteomics genomics cancer prevention and therapy
  • 相关文献

参考文献20

  • 1Wasinger V C,Cordwell S J,Cerpa-Poljak A, et al. Progress with gene-product mapping of the Mollicutes: My coplasma genitalium [J]. Electropho resis, 1995,16(7): 1090- 1094.
  • 2Shin B K, Wang H, Yim A M, et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function[J]. Biol Chem, 2003, 278 (9):7607-7616.
  • 3Paron I, Scaloni A, Pines A, et al. Nuclear localization of Galectin-3 in transformed thyroid cells: a role in transcriptional reg ulation[J]. BiochemBiophysResCommun, 2003,302(3): 545-553.
  • 4Rimm D I, Cam R L, Charette L A, et al. Tissue microarray: a new technology for amplification of tissue resources[J]. Cancer J, 2001, 7(1): 24-31.
  • 5Kallioniemi O P, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer[J]. Hum Mol Genet, 2001, 10(7): 657-662.
  • 6Rhodes D R, Sanda M G, Otte A P, et al. Multiplex biomarker approach for determining risk of prostate specific antigen-defined recurrence of prostate cancer [J]. Natl Cancer Inst, 2003, 95(9): 634-635.
  • 7Petricoin E F, ArdekaniA M, Hiu B A, et al. Use of proteomic patterns in serum toidentify ovarian cancer [J]. Lancet, 2002,359(9306): 572-577.
  • 8Rosty C, ChristaL, Kuzdzal S, et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology [J]. Cancer Res, 2002, 62(6): 1868-1875.
  • 9Sauter E R, ZhuW, Fan X J, et al. Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer [J]. Br J Cancer, 2002, 86(9): 1440-1443.
  • 10Luftner D, Possinger K. Nuclear matrix proteins as biomarkers for breast cancer [J]. Expert Rev Mol Diagn, 2002, 2(1): 23-31.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部